Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

Rang in aandelen #2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aandeelprijs
$17.34
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$9.98B
Verandering (1 dag)
-3.08%
Verandering (1 jaar)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)

Categorie

Healthcare
Aandelsplitsingen voor Aurobindo Pharma Limited (AUROPHARMA)
Het aandeel Aurobindo Pharma Limited (symbool: AUROPHARMA) heeft in totaal 5 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jul 20, 2015.
Eén aandeel AUROPHARMA dat vóór Oct 26, 1998 werd gekocht, staat nu gelijk aan 80 aandelen AUROPHARMA.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2015-07-20 2:1 x2 x80
2011-02-10 5:1 x5 x40
2003-10-23 2:1 x2 x8
2000-03-20 2:1 x2 x4
1998-10-26 2:1 x2 x2
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten